Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength

Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength

US Patent 9188597 · Granted Nov 17, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Detection of restensosis risk in patients receiving a stent2021
Assessment of cardiac health and thrombotic risk in a patient2020
Detection of restensosis risk in patients receiving a stent2018
Assessment of cardiac health and thrombotic risk in a patient2017
Assessment of cardiac health and thrombotic risk in a patient2015
Assessment of cardiac health and thrombotic risk in a patient2013
Detection of restenosis risk in patients receiving a stent by measuring the char2011
Assessment of cardiac health and thrombotic risk in a patient2011
Assessment of cardiac health and thrombotic risk in a patient2008
Methods of inhibiting platelet activation with selective serotonin reuptake inhi2003
Methods of inhibiting platelet activation with selective serotonin reuptake inhi2001
Determining a treatment plan for patients undergoing thrombotic event by monitor2001